Breaking News Instant updates and real-time market news.

APY

Apergy

$24.07 /

+0.06 (+0.25%)

06:04
10/10/19
10/10
06:04
10/10/19
06:04

Apergy downgraded to Neutral from Overweight at Piper Jaffray

Piper Jaffray analyst Ian Macpherson downgraded Apergy to Neutral from Overweight with a price target of $27, down from $36. The analyst moved his Q3 estimate toward the low end of the company's guidance based on the "sharper decline" in the lower 48 states. Although artificial lift has been a relatively resilient pocket within domestic oilfield servics, it won't be immune from the intensifying activity headwinds, Macpherson tells investors in a research note.

  • 24

    Oct

  • 29

    Oct

  • 30

    Oct

APY Apergy
$24.07 /

+0.06 (+0.25%)

07/10/19 Citi
Citi downgrades Apergy to Neutral on 'several issues' into Q2 results
07/09/19 Citi
Apergy downgraded to Neutral from Buy at Citi
06/25/19 Jefferies
Apergy price target lowered to $37 from $48 at Jefferies
04/03/19 Piper Sandler
Apergy initiated with an Overweight at Piper Jaffray

TODAY'S FREE FLY STORIES

Earnings
RLJ Lodging Trust sees FY20 adjusted FFO $1.62-$1.77, consensus $1.79 » 16:32
02/25/20
02/25
16:32
02/25/20
16:32
RLJ

RLJ Lodging Trust

$14.66 /

-0.96 (-6.15%)

Sees FY20 CapEx…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Delek US raises quarterly dividend 3.3% to 31c per share » 16:32
02/25/20
02/25
16:32
02/25/20
16:32
DK

Delek US

$25.20 /

-1.475 (-5.53%)

Delek US announced today…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Novavax announces NanoFlu data from mice study published » 16:32
02/25/20
02/25
16:32
02/25/20
16:32
NVAX

Novavax

$7.96 /

-0.21 (-2.57%)

Novavax announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Mallinckrodt clearing path for shares to be revalued, says Stifel » 16:31
02/25/20
02/25
16:31
02/25/20
16:31
MNK

Mallinckrodt

$4.72 /

+0.52 (+12.38%)

Stifel analyst Annabel…

Stifel analyst Annabel Samimy says Mallinckrodt reined in its largest overhangs by announcing an agreement in principle on terms of a global settlement that would address all opioid-related claims for $1.6B in structured payments as well as a debt refinancing that would address its April 2020 debt obligation. The news addresses two out of three of the company's most pressing cash-calls, Samimy tells investors in a research note. Though it puts the Specialty Generics unit into Chapter 11 temporarily to manage liabilities, this is the beginning of Mallinckrodt "retaking control of its broader business and clearing a path for shares to be revalued," contends the analyst. Samimy believes the tentative plans and reduced uncertainty "go a long way toward refocusing on the value" of Mallinckrodt's portfolio. The analyst keeps a Hold rating on the shares with an $8 price target. Mallinckrodt closed Tuesday up 16% to $4.75.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
RLJ Lodging Trust reports Q4 adjusted FFO 41c, consensus 46c » 16:31
02/25/20
02/25
16:31
02/25/20
16:31
RLJ

RLJ Lodging Trust

$14.66 /

-0.96 (-6.15%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Turning Point Brands approves $50M share repurchase » 16:31
02/25/20
02/25
16:31
02/25/20
16:31
TPB

Turning Point Brands

$22.67 /

-1.13 (-4.75%)

The repurchase…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Caesars reports Q4 EPS (45c), may not compare to consensus (11c) » 16:31
02/25/20
02/25
16:31
02/25/20
16:31
CZR

Caesars

$13.33 /

-0.69 (-4.92%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Vistra Energy increases dividend 8% to 13.5c » 16:31
02/25/20
02/25
16:31
02/25/20
16:31
VST

Vistra Energy

$22.13 /

-0.84 (-3.66%)

Vistra Energy announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Delek US reports Q4 EPS (11c), consensus 6c » 16:31
02/25/20
02/25
16:31
02/25/20
16:31
DK

Delek US

$25.20 /

-1.475 (-5.53%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Turning Point Brands raises quarterly dividend 11% to 5c per share » 16:30
02/25/20
02/25
16:30
02/25/20
16:30
TPB

Turning Point Brands

$22.67 /

-1.13 (-4.75%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Preliminary option volume of 40.7M today » 16:30
02/25/20
02/25
16:30
02/25/20
16:30

Preliminary option volume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Barrett Business sees FY20 EPS $5.05, consensus $6.13 » 16:29
02/25/20
02/25
16:29
02/25/20
16:29
BBSI

Barrett Business

$78.25 /

-2.67 (-3.30%)

This includes an increase…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Disney down 2.5% or over $3 at $125 per share after naming Bob Chapek new CEO  16:28
02/25/20
02/25
16:28
02/25/20
16:28
DIS

Disney

$128.24 /

-4.79 (-3.60%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Barrett Business reports Q4 EPS $1.51, consensus $1.28 » 16:28
02/25/20
02/25
16:28
02/25/20
16:28
BBSI

Barrett Business

$78.25 /

-2.67 (-3.30%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Ashford Hospitality reports Q2 AFFO 22c, consensus 18c » 16:28
02/25/20
02/25
16:28
02/25/20
16:28
AHT

Ashford Hospitality

$2.23 /

-0.235 (-9.53%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Vanda Pharma: Phase 3 study of tradipitant did not meet primary endpoint » 16:27
02/25/20
02/25
16:27
02/25/20
16:27
VNDA

Vanda Pharmaceuticals

$11.51 /

-0.28 (-2.37%)

Vanda Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Inspire Medical sees FY20 revenue $115M- $119M, consensus $108.8M » 16:27
02/25/20
02/25
16:27
02/25/20
16:27
INSP

Inspire Medical

$78.45 /

-1.48 (-1.85%)

Inspire expects full year…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
One Liberty acquires two industrial properties, sells one retail property » 16:27
02/25/20
02/25
16:27
02/25/20
16:27
OLP

One Liberty Properties

$26.76 /

-0.74 (-2.69%)

One Liberty Properties…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Inspire Medical reports Q4 EPS (38c), consensus (40c) » 16:26
02/25/20
02/25
16:26
02/25/20
16:26
INSP

Inspire Medical

$78.45 /

-1.48 (-1.85%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Amarin backs FY20 revenue view $650M-$700M, consensus $695.43M  16:26
02/25/20
02/25
16:26
02/25/20
16:26
AMRN

Amarin

$17.54 /

-0.05 (-0.28%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
WW up 7.7% after reporting Q4 results, giving FY20 guidance  16:25
02/25/20
02/25
16:25
02/25/20
16:25
WW

WW

$34.88 /

-2.01 (-5.45%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Jumia Technologies price target lowered to $8 from $10 at Stifel » 16:25
02/25/20
02/25
16:25
02/25/20
16:25
JMIA

Jumia Technologies

$3.98 /

-1.54 (-27.90%)

Stifel analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
JBG Smith Properties reports Q4 core FFO 39c, consensus 44c » 16:25
02/25/20
02/25
16:25
02/25/20
16:25
JBGS

JBG Smith Properties

$40.12 /

-1.11 (-2.69%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
WW says member recruitment in 2020 well above prior year » 16:25
02/25/20
02/25
16:25
02/25/20
16:25
WW

WW

$34.88 /

-2.01 (-5.45%)

"2020 is off to a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Castlight Health sees FY20 adjusted EPS (15c)-(12c), consensus (10c) » 16:25
02/25/20
02/25
16:25
02/25/20
16:25
CSLT

Castlight Health

$1.29 /

-0.035 (-2.64%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.